BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 21056989)

  • 1. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
    Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPC protects against smoking- and carcinogen-induced lung adenocarcinoma.
    Zhou H; Saliba J; Sandusky GE; Sears CR
    Carcinogenesis; 2019 May; 40(3):403-411. PubMed ID: 30624620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic instability in mutant p53 cancer cells upon entotic engulfment.
    Mackay HL; Moore D; Hall C; Birkbak NJ; Jamal-Hanjani M; Karim SA; Phatak VM; Piñon L; Morton JP; Swanton C; Le Quesne J; Muller PAJ
    Nat Commun; 2018 Aug; 9(1):3070. PubMed ID: 30076358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma.
    Chen R; Lo HH; Yang C; Law BYK; Chen X; Lam CCI; Ho C; Cheong HL; Li Q; Zhong C; Ng JPL; Peter CKF; Wong VKW
    Phytomedicine; 2024 Feb; 124():155310. PubMed ID: 38215574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XPC Protects against Carcinogen-Induced Histologic Progression to Lung Squamous Cell Carcinoma by Reduced Basal Epithelial Cell Proliferation.
    Sears CR; Zhou H; Hulsey E; Aidoo BA; Sandusky GE; Al Nasrallah N
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.
    He J; Zhu Q; Wani G; Sharma N; Han C; Qian J; Pentz K; Wang QE; Wani AA
    J Biol Chem; 2014 Sep; 289(39):27278-27289. PubMed ID: 25118285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites.
    Ray A; Milum K; Battu A; Wani G; Wani AA
    DNA Repair (Amst); 2013 Apr; 12(4):273-83. PubMed ID: 23422745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide excision repair factor XPC enhances DNA damage-induced apoptosis by downregulating the antiapoptotic short isoform of caspase-2.
    Wang QE; Han C; Zhang B; Sabapathy K; Wani AA
    Cancer Res; 2012 Feb; 72(3):666-75. PubMed ID: 22174370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas.
    Rezvani HR; Kim AL; Rossignol R; Ali N; Daly M; Mahfouf W; Bellance N; Taïeb A; de Verneuil H; Mazurier F; Bickers DR
    J Clin Invest; 2011 Jan; 121(1):195-211. PubMed ID: 21123941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical prognostic significance of xeroderma pigmentosum group C and IFN‑γ in non‑small cell lung cancer.
    Wang Y; Wang W; Wang H; Qin L; Zhang M; Zhang Y; Wang Y; Hao C; Qu M; Wang G
    Oncol Lett; 2024 Jun; 27(6):259. PubMed ID: 38646492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline.
    Zhu Y; Chen J; Li J; Zhou C; Huang X; Chen B
    Front Immunol; 2023; 14():1070679. PubMed ID: 36817446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.
    Nasrallah NA; Wiese BM; Sears CR
    Front Oncol; 2022; 12():846965. PubMed ID: 35530314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Patho-mechanisms of cervical cancer (MMP1).
    Kurnia I; Rauf S; Hatta M; Arifuddin S; Hidayat YM; Natzir R; Kaelan C; Bukhari A; Pelupessy NU; Patelonggi IJ
    Ann Med Surg (Lond); 2022 May; 77():103415. PubMed ID: 35444805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening the components of Saussurea involucrata for novel targets for the treatment of NSCLC using network pharmacology.
    Zhang D; Zhang T; Zhang Y; Li Z; Li H; Zhang Y; Liu C; Han Z; Li J; Zhu J
    BMC Complement Med Ther; 2022 Feb; 22(1):53. PubMed ID: 35227278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hou L; Li Y; Wang Y; Xu D; Cui H; Xu X; Cong Y; Yu C
    Dis Markers; 2018; 2018():4108919. PubMed ID: 30420903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SWIM: a computational tool to unveiling crucial nodes in complex biological networks.
    Paci P; Colombo T; Fiscon G; Gurtner A; Pavesi G; Farina L
    Sci Rep; 2017 Mar; 7():44797. PubMed ID: 28317894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.
    Sun CC; Li SJ; Yuan ZP; Li DJ
    Aging (Albany NY); 2016 Oct; 8(10):2509-2524. PubMed ID: 27777383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PATZ1 induces PP4R2 to form a negative feedback loop on IKK/NF-κB signaling in lung cancer.
    Ho MY; Liang CM; Liang SM
    Oncotarget; 2016 Aug; 7(32):52255-52269. PubMed ID: 27391343
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.